The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Regression of Human Cirrhosis: Morphologic Features and the Genesis of Incomplete Septal Cirrhosis
Abstract
Context. —Cirrhosis is widely regarded as being irreversible. Recent studies have demonstrated that fibrosis may decrease with time in humans and experimental animals if the disease activity becomes quiescent. The histologic appearance of regressing cirrhosis in the human has not been described in detail. Objectives. —To define histologic parameters that indicate regression of cirrhosis and to provide an interpretation of how regression occurs from a histologic point of view. Design. —A patient who underwent a series of biopsies that showed apparent regression of hepatitis B cirrhosis is presented. In addition, 52 livers removed at transplantation having cirrhosis or incomplete septal cirrhosis were graded for histologic parameters that suggest progression or regression of fibrosis. Progression parameters were steatohepatitis, inflammation, bridging necrosis, and piecemeal necrosis. The regression parameters (collectively called the hepatic repair complex) were delicate perforated septa, isolated thick collagen fibers, delicate periportal fibrous spikes, portal tract remnants, hepatic vein remnants with prolapsed hepatocytes, hepatocytes within portal tracts or splitting septa, minute regenerative nodules, and aberrant parenchymal veins. Results and Conclusions. —Regression parameters were found in all livers and were prominent in the majority. Livers with micronodular cirrhosis, macronodular cirrhosis, and incomplete septal cirrhosis demonstrate a histologic continuum. A continuum of regressive changes was also seen within individual livers. These appearances allow one to understand visually how fibrous regions of hepatic parenchyma can be returned toward a normal appearance. Many examples of incomplete septal cirrhosis could be the product of regressed cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Capillarization of hepatic sinusoids in man
Schaffner, F., & Popper, H. (1963) · Gastroenterology · doi:10.1016/s0016-5085(63)80130-4 · Cited by 610
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
Carbon tetrachloride cirrhosis in relation to liver regeneration
Cameron, G. R., & Karunaratne, W. A. E. (1936) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700420104 · Cited by 358
Colchicine in the Treatment of Cirrhosis of the Liver
Kershenobich, D., Vargas, F., Garcia-Tsao, G., Tamayo, R. P., Gent, M., & Rojkind, M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182602 · Cited by 328
Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis
Dufour, J.-F., DeLellis, R., & Kaplan, M. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00006 · Cited by 290
Long Term Results of Venesection Therapy in Idiopathic Haemochromatosis
(1976) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067484 · Cited by 269
10-year follow-up after interferon-α therapy for chronic hepatitis C
Lau, D. T., Kleiner, D. E., Ghany, M. G., Park, Y., Schmid, P., & Hoofnagle, J. H. (1998) · Hepatology · doi:10.1002/hep.510280430 · Cited by 266
Sobesky, R., Mathurin, P., Charlotte, F., Moussalli, J., Olivi, M., Vidaud, M., Ratziu, V., Opolon, P., & Poynard, T. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70135-6 · Cited by 252
Cited by
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
Ferraioli, G., Tinelli, C., Dal Bello, B., Zicchetti, M., Filice, G., Filice, C., & on behalf of the Liver Fibrosis Study Group (2012) · Hepatology · doi:10.1002/hep.25936 · Cited by 667
Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications
Friedman, S. L. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0055 · Cited by 498
Issa, R., Zhou, X., Constandinou, C. M., Fallowfield, J., Millward-Sadler, H., Gaca, M. D. A., Sands, E., Suliman, I., Trim, N., & Knorr, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.009 · Cited by 456
Metadata
- Authors
- Wanless, I. R., Nakashima, E., & Sherman, M.
- Venue
- Archives of Pathology & Laboratory Medicine
- Published
- 2000-11
- Volume
- 124
- Issue
- 11
- Pages
- 1599-1607
- ISSN
- 0003-9985 (ISSN-L)
- 1543-2165
- OpenAlex
- W1936551240
- Cited by
- 339
- References
- 33
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regression of Human Cirrhosis: Morphologic Features and the Genesis of Incomplete Septal Cirrhosis. https://app.cochat.ai/papers/10.5858/2000-124-1599-rohc
- The paper
- Wanless, I. R., Nakashima, E., & Sherman, M. (2000). Regression of Human Cirrhosis: Morphologic Features and the Genesis of Incomplete Septal Cirrhosis. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/2000-124-1599-rohc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.